Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Rationale for Use of Recombinant Human Growth Hormone (rhGH) in Patients With CF
The rationale for the use of rhGH as an adjuvant therapy for patients with CF is based on the observation that despite an aggressive focus on treatment of nutritional needs as part of standard care, as many as one-third of patients with CF in the United States fall below the 10th percentile in height and weight. Patients with CF experience increased energy expenditure due to the high metabolic demands of their chronic illness. Better clinical outcomes for patients with CF have been associated with measures that improve growth. This finding has led investigators to suggest that treatment with the anabolic hormone rhGH may lead to better intermediate and long-term health outcomes and improved quality of life for patients with CF.
Keywords: nutrition | nutritional | deficiencies | deficiency | malnutrition | anabolic | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
- Lai HC, Kosorok MR, Sondel SA, et al. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr 1998;132(3 Pt 1):478-85.
- Columbo C, Battezzati A. Growth failure in cystic fibrosis: a true need for anabolic agents? [comment]. J Pediatr 2005;146:303-5.
- Konstan MW, Buler SM, Wohl ME, et al. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003;142:624-30.
- Beker LT, Russek-Cohen E, Fink RJ. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc 2001;101:438-42.
- Ramsey BW, Farell PM, Pencharz P, and the Consensus Committee. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992;55:108-16.
- Phung OJ, Coleman CI, Baker EL, et al. Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Cystic Fibrosis. AHRQ Comparative Effectiveness Review No. 23 (Prepared by University of Connecticut-Hartford Hospital Evidence-based Practice Center under Contract No. 290-2007-10067-I). Rockville, MD: Agency for Healthcare Research and Quality; October 2010. AHRQ Publication No. 11-EHC003-EF.
Your slide tray is being processed.